Centro Médico ASISA

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Asthma2 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Chiesi Farmaceutici S.p.A.1 trial
• Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S.A.1 trial

Running trials

• Active, not recruiting

  Study to evaluate the safety and efficacy of a treatment consisting of immunotherapy by subcutaneous injection of a combination of Der p 1/Der p 2/Der p 23 allergens at different doses in patients with allergic rhinitis or rhinoconjunctivitis with or without allergic asthma.

  2024-518519-20-01· Phase 2· Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S.A.· Source

Closed trials

• Completed

  Comparison Between CHF5993 pMDI 200/6/12.5 µg HFA-152a VS CHF5993 pMDI 200/6/12.5 µg HFA-134a in Subjects With Asthma (TRECOS).

  NCT06264674· Phase 3· Chiesi Farmaceutici S.p.A.· Source